Neopterin in HIV-1 infection

被引:76
作者
Wirleitner, B
Schroecksnadel, K
Winkler, C
Fuchs, D
机构
[1] Med Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
[2] Ludwig Boltzmann Inst AIDS Res, A-6020 Innsbruck, Austria
关键词
HIV-1; neopterm; chronic immune activation; interferon-gamma;
D O I
10.1016/j.molimm.2004.06.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neopterin is well established as a reliable marker in HIV- 1 infection. Neopterin concentrations measured in urine or serum indicate sensitively the course and progression of the disease as well as efficacy of anti-retroviral therapy. The main trigger for neopterin production is Th1-type cytokine interferon-gamma. During acute HIV-1 infection, enhanced formation of neopterin occurs already at a very early time point, before antibody seroconversion takes place. After this stage, neopterin concentrations in serum and urine closely correlate with virus load in the circulation of HIV-1 -infected patients. Data provide evidence for an important role of immune activation and Th 1 -type cytokine interferon-gamma in the pathogenesis of HIV-1 infection. This review subsumes the importance of neopterin as a marker in HIV- I infection. Further evidence is increasing, that neopterin derivatives might modulate immune response by interfering with the cellular redox balance, activating redox-sensitive transcription factors, or inducing apoptosis in specific cell types. The possible impact of neopterin derivatives and of other biochemical pathways induced by interferon-gamma such as indoleamine 2,3-dioxygenase in chronic diseases like HIV- 1 infection is discussed. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:183 / 194
页数:12
相关论文
共 129 条
[1]   Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals - Correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels [J].
Andersson L.M. ;
Hagberg L. ;
Fuchs D. ;
Svennerholm B. ;
Gisslén M. .
Journal of NeuroVirology, 2001, 7 (6) :542-547
[2]   7,8-dihydroneopterin upregulates interferon-gamma promoter in T cells [J].
BaierBitterlich, G ;
Fuchs, D ;
Wachter, H .
IMMUNOBIOLOGY, 1996, 196 (04) :350-355
[3]  
BaierBitterlich G, 1996, ONCOGENE, V13, P2281
[4]   EFFECT OF NEOPTERIN AND 7,8-DIHYDRONEOPTERIN ON TUMOR-NECROSIS-FACTOR-ALPHA INDUCED PROGRAMMED CELL-DEATH [J].
BAIERBITTERLICH, G ;
FUCHS, D ;
MURR, C ;
REIBNEGGER, G ;
WERNERFELMAYER, G ;
SGONC, R ;
BOCK, G ;
DIERICH, MP ;
WACHTER, H .
FEBS LETTERS, 1995, 364 (02) :234-238
[5]   trans-activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro [J].
BaierBitterlich, G ;
Fuchs, D ;
Zangerle, R ;
Baeuerle, PA ;
Werner, ER ;
Fresser, F ;
Uberall, F ;
Baier, G ;
Wachter, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (02) :173-178
[6]   INTERLEUKIN-2-INDUCED AND NEOPTERIN-INDUCED NEOPTERIN RELEASE FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
BARAK, M ;
MERZBACH, D ;
GRUENER, N .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1990, 50 (07) :705-714
[7]   NEOPTERIN AUGMENTATION OF TUMOR-NECROSIS-FACTOR PRODUCTION [J].
BARAK, M ;
GRUENER, N .
IMMUNOLOGY LETTERS, 1991, 30 (01) :101-106
[8]  
BASS HZ, 1992, J ACQ IMMUN DEF SYND, V5, P215
[9]   Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis [J].
Baumer, I ;
Zissel, G ;
Schlaak, M ;
MullerQuernheim, J .
LUNG, 1997, 175 (02) :105-116
[10]   MEASUREMENT OF URINARY NEOPTERIN IN NORMAL PREGNANT AND NON-PREGNANT WOMEN AND IN WOMEN WITH BENIGN AND MALIGNANT GENITAL-TRACT NEOPLASMS [J].
BICHLER, A ;
FUCHS, D ;
HAUSEN, A ;
HETZEL, H ;
REIBNEGGER, G ;
WACHTER, H .
ARCHIVES OF GYNECOLOGY, 1983, 233 (02) :121-130